40 results on '"Schmutzhard, Erich"'
Search Results
2. Characteristics of people with epilepsy in three Eastern African countries – a pooled analysis
- Author
-
Stelzle, Dominik, Kaducu, Joyce, Schmidt, Veronika, Welte, Tamara M., Ngowi, Bernard J., Matuja, William, Escheu, Gabrielle, Hauke, Peter, Richter, Vivien, Ovuga, Emilio, Pfausler, Bettina, Schmutzhard, Erich, Amos, Action, Harrison, Wendy, Keller, Luise, and Winkler, Andrea S.
- Published
- 2022
- Full Text
- View/download PDF
3. Hemodynamic response during endotracheal suctioning predicts awakening and functional outcome in subarachnoid hemorrhage patients
- Author
-
Rass, Verena, Ianosi, Bogdan-Andrei, Lindner, Anna, Kofler, Mario, Schiefecker, Alois J., Pfausler, Bettina, Beer, Ronny, Schmutzhard, Erich, and Helbok, Raimund
- Published
- 2020
- Full Text
- View/download PDF
4. A long-term follow-up study on otoacoustic emissions testing in paediatric patients with severe malaria in Gabon
- Author
-
Reiterer, Elisa, Reider, Simon, Lackner, Peter, Fischer, Natalie, Dejaco, Daniel, Riechelmann, Herbert, Zorowka, Patrick, Kremsner, Peter G., Adegnika, Ayola Akim, Schmutzhard, Erich, and Schmutzhard, Joachim
- Published
- 2019
- Full Text
- View/download PDF
5. Autoantibodies against neuronal surface proteins in spontaneous subarachnoid and intracerebral haemorrhage
- Author
-
Hegen, Harald, Helbok, Raimund, Kofler, Mario, Pfausler, Bettina, Schiefecker, Alois, Schmutzhard, Erich, and Beer, Ronny
- Published
- 2018
- Full Text
- View/download PDF
6. Early brain injury after aneurysmal subarachnoid hemorrhage: a multimodal neuromonitoring study
- Author
-
Helbok, Raimund, Schiefecker, Alois Josef, Beer, Ronny, Dietmann, Anelia, Antunes, Ana Patrícia, Sohm, Florian, Fischer, Marlene, Hackl, Werner Oskar, Rhomberg, Paul, Lackner, Peter, Pfausler, Bettina, Thomé, Claudius, Humpel, Christian, and Schmutzhard, Erich
- Published
- 2015
- Full Text
- View/download PDF
7. Complications of hypothermia: infections
- Author
-
Broessner, Gregor, Fischer, Marlene, Lackner, Peter, Pfausler, Bettina, and Schmutzhard, Erich
- Published
- 2012
- Full Text
- View/download PDF
8. Therapeutic hypothermia: the rationale
- Author
-
Schmutzhard, Erich, Fischer, Marlene, Dietmann, Anelia, and Brössner, Gregor
- Published
- 2012
- Full Text
- View/download PDF
9. Update on therapeutic temperature management
- Author
-
Broessner, Gregor, Fischer, Marlene, Schubert, Gerrit, Metzler, Bernhard, and Schmutzhard, Erich
- Published
- 2012
- Full Text
- View/download PDF
10. Rewarming: facts and myths from the neurological perspectives
- Author
-
Schmutzhard, Erich, Fischer, Marlene, Dietmann, Anelia, Helbok, Raimund, and Broessner, Gregor
- Published
- 2012
- Full Text
- View/download PDF
11. Controlled prophylactic normothermia
- Author
-
Broessner, Gregor, Fischer, Marlene, Pfausler, Bettina, and Schmutzhard, Erich
- Published
- 2012
- Full Text
- View/download PDF
12. Phase 2/3 study of intravenous thrombolysis and hypothermia for acute treatment of ischemic stroke (ICTuS 2/3)
- Author
-
Hemmen, Thomas, Rapp, Karen, Raman, Rema, Concha, Mauricio, Brössner, Gregor, Schmutzhard, Erich, Tafreshi, Gilda, Misra, Vivek, Cruz-Flores, Salvador, Kollmar, Rainer, Brown, David, Altafullah, Irfan, Michel, Patrik, Alexandrov, Andrei, Smith, Carlos, Jurf, Julie, Hess, Mary Jane, Grotta, James, and Lyden, Patrick D
- Published
- 2012
- Full Text
- View/download PDF
13. Temperature management in central nervous infection
- Author
-
Schmutzhard, Erich, Lackner, Peter, Beer, Ronny, Fischer, Marlene, Dietmann, Anelia, and Pfausler, Bettina
- Published
- 2012
- Full Text
- View/download PDF
14. Hypothermia and advanced neuromonitoring
- Author
-
Helbok, Raimund, Schiefecker, Alois, Fischer, Marlene, Dietmann, Anelia, and Schmutzhard, Erich
- Published
- 2012
- Full Text
- View/download PDF
15. Hypothermia and nutrition: at present more questions than answers?
- Author
-
Beer, Ronny, Fischer, Marlene, Dietmann, Anelia, Pfausler, Bettina, and Schmutzhard, Erich
- Published
- 2012
- Full Text
- View/download PDF
16. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study.
- Author
-
Tegtmeier, Frank, Schinzel, Reinhard, Beer, Ronny, Bulters, Diederik, LeFrant, Jean-Yves, Sahuquillo, Joan, Unterberg, Andreas, Andrews, Peter, Belli, Antonio, Ibanez, Javier, Lagares, Alfonso, Mokry, Michael, Willschke, Harald, Flühe, Charlotte, Schmutzhard, Erich, NOSTRA Investigators, and Flüh, Charlotte
- Subjects
BRAIN injuries ,GLASGOW Coma Scale ,PATIENT safety ,INTRACRANIAL pressure ,INTRAVENOUS therapy ,MOLECULAR probes ,PERIODONTAL probe - Abstract
Background: Traumatic brain injury is a leading cause of death and disability worldwide. The nitric oxide synthase inhibitor Ronopterin was shown to improve clinical outcome by enhancing neuroprotection in a phase IIa trial.Methods/design: The NOSTRA phase III trial (Ronopterin in traumatic brain injury) is a multi-centre, prospective, randomised, double-blinded, placebo-controlled, phase III trial in Europe. It aims at determining whether the administration of Ronopterin compared to placebo improves neurological outcome in patients with moderate or severe traumatic brain injury at 6 months after injury. The trial is designed to recruit patients between 18 and 60 years of age with moderate or severe traumatic brain injury (Glasgow Coma Scale score ≥ 3) and requiring insertion of an intracranial pressure probe. Trial patients will receive a 48-h intravenous infusion of either Ronopterin or placebo starting at the earliest 6 h and at the latest 18 h after injury. The primary outcome will be the extended Glasgow Outcome Score (eGOS) at 6 months. Secondary outcomes will include the Quality of Life Index (QOLIBRI) at 6 months after the injury and the eGOS at 3 months after the injury. Additionally, effects on mortality, intracranial pressure and cerebral perfusion pressure are evaluated.Discussion: The trial aims to provide evidence on the efficacy and safety of Ronopterin in patients with traumatic brain injury.Trial Registration: EudraCT, 2013-003368-29. Registered on 9 March 2016. ClinicalTrials.gov, NCT02794168. Registered on 8 June 2016. Protocol version 14.0 from 05 November 2018. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
17. Erratum to: Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions - a prospective multicenter cohort study
- Author
-
Schmutzhard, Joachim, Lackner, Peter, Helbok, Raimund, Hurth, Helene Verena, Aregger, Fabian Cedric, Muigg, Veronika, Kegele, Josua, Bunk, Sebastian, Oberhammer, Lukas, Fischer, Natalie, Pinggera, Leyla, Otieno, Allan, Ogutu, Bernards, Agbenyega, Tsiri, Ansong, Daniel, Adegnika, Ayola A., Issifou, Saadou, Zorowka, Patrick, Krishna, Sanjeev, Mordmüller, Benjamin, Schmutzhard, Erich, and Kremsner, Peter
- Subjects
Medicine(all) ,Male ,Otoacoustic Emissions, Spontaneous ,Malaria, Cerebral ,General Medicine ,Ghana ,Kenya ,Cohort Studies ,Child, Preschool ,Humans ,Female ,Gabon ,Prospective Studies ,Erratum ,Malaria, Falciparum ,Child ,Hearing Loss - Abstract
Severe malaria may influence inner ear function, although this possibility has not been examined prospectively. In a retrospective analysis, hearing impairment was found in 9 of 23 patients with cerebral malaria. An objective method to quickly evaluate the function of the inner ear are the otoacoustic emissions. Negative transient otoacoustic emissions are associated with a threshold shift of 20 dB and above.This prospective multicenter study analyses otoacoustic emissions in patients with severe malaria up to the age of 10 years. In three study sites (Ghana, Gabon, Kenya) 144 patients with severe malaria and 108 control children were included. All malaria patients were treated with parental artesunate.In the control group, 92.6 % (n = 108, 95 % confidence interval 86.19-6.2 %) passed otoacoustic emission screening. In malaria patients, 58.5 % (n = 94, malaria vs controls p0.001, 95 % confidence interval 48.4-67.9 %) passed otoacoustic emission screening at the baseline measurement. The value increased to 65.2 % (n = 66, p0.001, 95 % confidence interval 53.1-75.5 %) at follow up 14-28 days after diagnosis of malaria. The study population was divided into severe non-cerebral malaria and severe malaria with neurological symptoms (cerebral malaria). Whereas otoacoustic emissions in severe malaria improved to a passing percentage of 72.9 % (n = 48, 95 % confidence interval 59-83.4 %) at follow-up, the patients with cerebral malaria showed a drop in the passing percentage to 33 % (n = 18) 3-7 days after diagnosis. This shows a significant impairment in the cerebral malaria group (p = 0.012 at days 3-7, 95 % confidence interval 16.3-56.3 %; p = 0.031 at day 14-28, 95 % confidence interval 24.5-66.3 %).The presented data show that 40 % of children have involvement of the inner ear early in severe malaria. In children, audiological screening after severe malaria infection is not currently recommended, but is worth investigating in larger studies.
- Published
- 2016
18. Case report: severe heat stroke with multiple organ dysfunction – a novel intravascular treatment approach
- Author
-
Broessner, Gregor, Beer, Ronny, Franz, Gerhard, Lackner, Peter, Engelhardt, Klaus, Brenneis, Christian, Pfausler, Bettina, and Schmutzhard, Erich
- Subjects
Research - Abstract
Introduction We report the case of a patient who developed a severe post-exertional heat stroke with consecutive multiple organ dysfunction resistant to conventional antipyretic treatment, necessitating the use of a novel endovascular device to combat hyperthermia and maintain normothermia. Methods A 38-year-old male suffering from severe heat stroke with predominant signs and symptoms of encephalopathy requiring acute admission to an intensive care unit, was admitted to a ten-bed neurological intensive care unit of a tertiary care hospital. The patient developed consecutive multiple organ dysfunction with rhabdomyolysis, and hepatic and respiratory failure. Temperature elevation was resistant to conventional treatment measures. Aggressive intensive care treatment included forced diuresis and endovascular cooling to combat hyperthermia and maintain normothermia. Results Analyses of serum revealed elevation of proinflammatory cytokines (TNF alpha, IL-6), cytokines (IL-2R), anti-inflammatory cytokines (IL-4) and chemokines (IL-8) as well as signs of rhabdomyolysis and hepatic failure. Aggressive intensive care treatment as forced diuresis and endovascular cooling (CoolGard® and CoolLine®) to combat hyperthermia and maintain normothermia were used successfully to treat this severe heat stroke. Conclusion In this case of severe heat stroke, presenting with multiple organ dysfunction and elevation of cytokines and chemokines, which was resistant to conventional cooling therapies, endovascular cooling may have contributed significantly to the reduction of body temperature and, possibly, avoided a fatal result.
- Published
- 2005
19. Bi-insular cortical involvement in anti-NMDA-receptor encephalitis - a case report.
- Author
-
Hegen, Harald, Uprimny, Christian, Grams, Astrid, Virgolini, Irene, Ramberger, Melanie, Beer, Ronny, Helbok, Raimund, Pfausler, Bettina, and Schmutzhard, Erich
- Subjects
METHYL aspartate receptors ,ENCEPHALITIS ,MAGNETIC resonance imaging of the brain ,INSULAR cortex ,HIPPOCAMPUS (Brain) ,TEMPORAL lobe ,FRONTAL lobe ,CEREBROSPINAL fluid - Abstract
Background: Anti-NMDA-receptor encephalitis is an immune-mediated inflammatory disorder of the central nervous system. Brain MRI is unremarkable in at least 50% of patients and highly variable in the remaining patients with signal abnormalities in different brain regions. Only scarce reports exist on other imaging modalities.Case Presentation: A 31-year-old woman sub-acutely developed psychosis, behavioural changes, amnesia, alternating states of agitation and mutism, fever and epileptic seizures. Clinically suspected diagnosis of anti-NMDA-receptor encephalitis was confirmed by the detection of anti-NMDA receptor antibodies in CSF and serum. During the acute phase, brain MRI abnormalities were found in both insular cortices and hippocampi, whereas F(18)-FDG-PET showed hypermetabolism bilaterally in insular and prefrontal cortex. After resection of the underlying ovarian teratoma and with multimodal immunotherapy the patient substantially improved reaching a modified Rankin Scale score of 2 after 3 months. At follow-up, both hippocampi were still affected on MRI, whereas insular cortex appeared normal; however, both regions showed prominent glucose hypometabolism.Conclusions: Here, we report bi-insular cortical abnormalities on MRI and F(18)-FDG-PET in a patient with anti-NMDA-receptor encephalitis during the acute phase and after clinical improvement. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
20. Remote ischemic preconditioning in the prevention of ischemic brain damage during intracranial aneurysm treatment (RIPAT): study protocol for a randomized controlled trial.
- Author
-
Tülü, Selma, Mulino, Miriam, Pinggera, Daniel, Luger, Markus, Würtinger, Philipp, Grams, Astrid, Bodner, Thomas, Beer, Ronny, Helbok, Raimund, Matteucci-Gothe, Raffaella, Unterhofer, Claudia, Gizewski, Elke, Schmutzhard, Erich, Thomé, Claudius, and Ortler, Martin
- Subjects
ISCHEMIC preconditioning ,CEREBRAL ischemia ,INTRACRANIAL aneurysm surgery ,RANDOMIZED controlled trials ,BIOMARKERS ,MAGNETIC resonance imaging ,INTRACRANIAL aneurysm diagnosis ,INTRACRANIAL aneurysms ,ACADEMIC medical centers ,ARM ,BLOOD circulation ,FUNCTIONAL assessment ,EXPERIMENTAL design ,MICROSURGERY ,NEUROSURGERY ,ELECTIVE surgery ,THERAPEUTICS ,TIME ,DIAGNOSIS ,PREVENTION - Abstract
Background: The treatment of intracranial aneurysms may be associated with cerebral ischemia. We hypothesize that pre-interventional remote ischemic preconditioning (RIPC) reduces ischemic cerebral tissue damage in patients undergoing elective intracranial aneurysm treatment.Methods/design: This study is a single-center, prospective, randomized, double-blind explorative trial. Patients with an unruptured intracranial aneurysm admitted to Innsbruck Medical University Hospital for coiling or clipping will be consecutively randomized to either the intervention group (= RIPC by inflating an upper extremity blood-pressure cuff for 3 x 5 min to 200 mmHg) or the control group after induction of anesthesia. Participants will be randomized 1:1 to either the preconditioning group or the sham group using a random allocation sequence and block randomization. The precalculated sample size is n = 24 per group. The primary endpoint is the area-under-the-curve concentration of serum biomarkers (S100B, NSE, GFAP, MMP9, MBP, and cellular microparticles) in the first five days after treatment. Secondary endpoints are the number and volume of new ischemic lesions in magnetic resonance imaging and clinical outcome evaluated with the National Institutes of Health Stroke Scale, the modified Rankin Scale, and neuropsychological tests at six and twelve months. All outcome variables will be determined by observers blinded to group allocation. This study was approved by the local institutional Ethics Committee (UN5164), version 3.0 of the study protocol, dated 20 October 2013.Discussion: This study uses the elective treatment of intracranial aneurysms as a paradigmatic situation to explore the neuroprotective effects of RIPC. If effects are demonstrable in this pilot trial, a larger, prospective phase III trial will be considered. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
21. Higher brain extracellular potassium is associated with brain metabolic distress and poor outcome after aneurysmal subarachnoid hemorrhage.
- Author
-
Antunes, Ana Patrícia, Schiefecker, Alois Josef, Beer, Ronny, Pfausler, Bettina, Sohm, Florian, Fischer, Marlene, Dietmann, Anelia, Lackner, Peter, Hackl, Werner O., Ndayisaba, Jean-Pierre, Thomé, Claudius, Schmutzhard, Erich, and Helbok, Raimund
- Published
- 2014
- Full Text
- View/download PDF
22. Parenteral diclofenac infusion significantly decreases brain-tissue oxygen tension in patients with poor-grade aneurysmal subarachnoid hemorrhage.
- Author
-
Schiefecker, Alois J., Pfausler, Bettina, Beer, Ronny, Sohm, Florian, Sabo, Jan, Knauseder, Viktoria, Fischer, Marlene, Dietmann, Anelia, Hackl, Werner O., Thomé, Claudius, Schmutzhard, Erich, and Helbok, Raimund
- Subjects
DICLOFENAC ,ANTIPYRETICS ,CRITICAL care medicine ,HEMORRHAGE ,HYPOXEMIA ,BODY temperature - Abstract
Introduction: Diclofenac, a nonsteroidal antiinflammatory drug, is commonly used as antipyretic therapy in intensive care. The purpose of this study was to investigate the effects of parenteral diclofenac infusion on brain homeostasis, including brain-tissue oxygen tension (P
b tO2 ) and brain metabolism after aneurysmal subarachnoid hemorrhage (aSAH). Methods: We conducted a prospective, observational study with retrospective analysis of 21 consecutive aSAH patients with multimodal neuromonitoring. Cerebral perfusion pressure (CPP), mean arterial pressure (MAP), intracranial pressure (ICP), body temperature, and Pb tO2 were analyzed after parenteral diclofenac infusion administered over a 34-minute period (20 to 45 IQR). Data are given as mean ± standard error of mean and median with interquartile range (IQR), as appropriate. Time-series data were analyzed by using a general linear model extended by generalized estimation equations (GEEs). Results: One-hundred twenty-three interventions were analyzed. Body temperature decreased from 38.3°C ± 0.05°C by 0.8°C ± 0.06°C (P < 0.001). A 10% decrease in MAP and CPP (P < 0.001) necessitated an increase of vasopressors in 26% (n = 32), colloids in 33% (n = 41), and crystalloids in 5% (n = 7) of interventions. Pb tO2 decreased by 13% from a baseline value of 28.1 ± 2.2 mm Hg, resulting in brain-tissue hypoxia (Pb tO2 <20 mm Hg) in 38% (n = 8) of patients and 35% (n = 43) of interventions. Pb tO2 <30 mm Hg before intervention was associated with brain-tissue hypoxia after parenteral diclofenac infusion (likelihood ratio, 40; AUC, 93%; 95% confidence interval (CI), 87% to 99%; P < 0.001). Cerebral metabolism showed no significant changes after parenteral diclofenac infusion. Conclusions: Parenteral diclofenac infusion after aSAH effectively reduces body temperature, but may lead to CPP decrease and brain-tissue hypoxia, which were both associated with poor outcome after aSAH. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
23. Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients.
- Author
-
Helbok, Raimund, Kurtz, Pedro, Schmidt, Michael J., Stuart, Morgan R., Fernandez, Luis, Connolly, Sander E., Lee, Kiwon, Schmutzhard, Erich, A Mayer, Stephan, Claassen, Jan, and Badjatia, Neeraj
- Subjects
NEUROLOGICAL intensive care ,MEDICAL screening ,INTRACRANIAL pressure ,BRAIN metabolism ,BRAIN damaged patients ,HYPERBARIC oxygenation ,INTENSIVE care units - Abstract
Introduction: Daily interruption of sedation (IS) has been implemented in 30 to 40% of intensive care units worldwide and may improve outcome in medical intensive care patients. Little is known about the benefit of IS in acutely brain-injured patients. Methods: This prospective observational study was performed in a neuroscience intensive care unit in a tertiary-care academic center. Twenty consecutive severely brain-injured patients with multimodal neuromonitoring were analyzed for levels of brain lactate, pyruvate and glucose, intracranial pressure (ICP), cerebral perfusion pressure (CPP) and brain tissue oxygen tension (P
bt O2 ) during IS trials. Results: Of the 82 trial days, 54 IS-trials were performed as interruption of sedation and analgesics were not considered safe on 28 days (34%). An increase in the FOUR Score (Full Outline of UnResponsiveness score) was observed in 50% of IS-trials by a median of three (two to four) points. Detection of a new neurologic deficit occurred in one trial (2%), and in one-third of IS-trials the trial had to be stopped due to an ICP-crisis (> 20 mmHg), agitation or systemic desaturation. In IS-trials that had to be aborted, a significant increase in ICP and decrease in Pbt O2 (P < 0.05), including 67% with critical values of Pbt O2 < 20 mmHg, a tendency to brain metabolic distress (P < 0.07) was observed. Conclusions: Interruption of sedation revealed new relevant clinical information in only one trial and a large number of trials could not be performed or had to be stopped due to safety issues. Weighing pros and cons of IS-trials in patients with acute brain injury seems important as related side effects may overcome the clinical benefit. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
24. High dose Erythropoietin increases Brain Tissue Oxygen Tension in Severe Vasospasm after Subarachnoid Hemorrhage.
- Author
-
Helbok, Raimund, Shaker, Ehab, Beer, Ronny, Chemelli, Andreas, Sojer, Martin, Sohm, Florian, Broessner, Gregor, Lackner, Peter, Beck, Monika, Zangerle, Alexandra, Pfausler, Bettina, Thome, Claudius, and Schmutzhard, Erich
- Subjects
ERYTHROPOIETIN ,CEREBRAL hemorrhage ,CEREBRAL ischemia ,BRAIN diseases ,BLOOD pressure - Abstract
Background: Vasospasm-related delayed cerebral ischemia (DCI) significantly impacts on outcome after aneurysmal subarachnoid hemorrhage (SAH). Erythropoietin (EPO) may reduce the severity of cerebral vasospasm and improve outcome, however, underlying mechanisms are incompletely understood. In this study, the authors aimed to investigate the effect of EPO on cerebral metabolism and brain tissue oxygen tension (P
b tO2 ). Methods: Seven consecutive poor grade SAH patients with multimodal neuromonitoring (MM) received systemic EPO therapy (30.000 IU per day for 3 consecutive days) for severe cerebral vasospasm. Cerebral perfusion pressure (CPP), mean arterial blood pressure (MAP), intracranial pressure (ICP), Pb tO2 and brain metabolic changes were analyzed during the next 24 hours after each dose given. Statistical analysis was performed with a mixed effects model. Results: A total of 22 interventions were analyzed. Median age was 47 years (32-68) and 86% were female. Three patients (38%) developed DCI. MAP decreased 2 hours after intervention (P<0.04) without significantly affecting CPP and ICP. Pb tO2 significantly increased over time (P<0.05) to a maximum of 7 ± 4 mmHg increase 16 hours after infusion. Brain metabolic parameters did not change over time. Conclusions: EPO increases Pb tO2 in poor grade SAH patients with severe cerebral vasospasm. The effect on outcome needs further investigation. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
25. Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage.
- Author
-
Fischer, Marlene, Broessner, Gregor, Dietmann, Anelia, Beer, Ronny, Helbok, Raimund, Pfausler, Bettina, Chemelli, Andreas, Schmutzhard, Erich, and Lackner, Peter
- Subjects
CEREBRAL vasospasm ,CEREBROVASCULAR disease ,CEREBRAL ischemia ,ISCHEMIA ,HOMEOSTASIS - Abstract
Background: Angiopoietin-1 (Ang-1) and -2 (Ang-2) are keyplayers in the regulation of endothelial homeostasis and vascular proliferation. Angiopoietins may play an important role in the pathophysiology of cerebral vasospasm (CVS). Ang-1 and Ang-2 have not been investigated in this regard so far. Methods: 20 patients with subarachnoid hemorrhage (SAH) and 20 healthy controls (HC) were included in this prospective study. Blood samples were collected from days 1 to 7 and every other day thereafter. Ang-1 and Ang- 2 were measured in serum samples using commercially available enzyme-linked immunosorbent assay. Transcranial Doppler sonography was performed to monitor the occurrence of cerebral vasospasm. Results: SAH patients showed a significant drop of Ang-1 levels on day 2 and 3 post SAH compared to baseline and HC. Patients, who developed Doppler sonographic CVS, showed significantly lower levels of Ang-1 with a sustained decrease in contrast to patients without Doppler sonographic CVS, whose Ang-1 levels recovered in the later course of the disease. In patients developing cerebral ischemia attributable to vasospasm significantly lower Ang-1 levels have already been observed on the day of admission. Differences of Ang-2 between SAH patients and HC or patients with and without Doppler sonographic CVS were not statistically significant. Conclusions: Ang-1, but not Ang-2, is significantly altered in patients suffering from SAH and especially in those experiencing CVS and cerebral ischemia. The loss of vascular integrity, regulated by Ang-1, might be in part responsible for the development of cerebral vasospasm and subsequent cerebral ischemia. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
26. Murine malaria is associated with significant hearing impairment.
- Author
-
Schmutzhard, Joachim, Kositz, Christian H., Lackner, Peter, Dietmann, Anelia, Fischer, Marlene, Glueckert, Rudolf, Reindl, Markus, Stephan, Kurt, Riechelmann, Herbert, Schrott-Fischer, Annelies, and Schmutzhard, Erich
- Subjects
MALARIA treatment ,HEARING disorders ,COGNITION disorders ,THERAPEUTICS ,MEDICAL research - Abstract
Background: Plasmodium falciparum malaria has been suspected to cause hearing loss. Developmental, cognitive and language disorders have been observed in children, surviving cerebral malaria. This prospective study aims to evaluate whether malaria influences hearing in mice. Methods: Twenty mice were included in a standardized murine cerebral malaria model. Auditory evoked brainstem responses were assessed before infection and at the peak of the illness. Results: A significant hearing impairment could be demonstrated in mice with malaria, especially the cerebral form. The control group did not show any alterations. No therapy was used. Conclusion: This suggests that malaria itself leads to a hearing impairment in mice. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
27. IgG-index predicts neurological morbidity inpatients with infectious central nervous systemdiseases.
- Author
-
Lackner, Peter, Guengoer, Elif, Beer, Ronny, Broessner, Gregor, Helbok, Raimund, Deisenhammer, Florian, Schmutzhard, Erich, and Pfausler, Bettina
- Subjects
PROGNOSIS ,CENTRAL nervous system diseases ,CEREBROSPINAL fluid ,MENINGITIS ,IMMUNOGLOBULINS - Abstract
Background: Prognosis assessment of patients with infectious and neoplastic disorders of the central nervous system (CNS) may still pose a challenge. In this retrospective cross-sectional study the prognostic value of basic cerebrospinal fluid (CSF) parameters in patients with bacterial meningitis, viral meningoencephalitis and leptomeningeal metastases were evaluated. Methods: White blood cell count, CSF/serum glucose ratio, protein, CSF/serum albumin quotient and Immunoglobulin indices for IgG, IgA and IgM were analyzed in 90 patients with bacterial meningitis, 117 patients with viral meningoencephalitis and 36 patients with leptomeningeal metastases in a total of 480 CSF samples. Results: In the initial spinal tap, the IgG-index was the only independent predictor for unfavorable outcome (GOS < 5) in patients with infectious CNS diseases but not in patients with leptomeningeal metastases. The sensitivity and specificity of an IgG-index of 0.75 and higher for predicting unfavorable outcome was 40.9% and 80.8% in bacterial meningitis and 40% and 94.8% in viral meningoencephalitis, respectively. No significant associations between CSF parameters and outcome could be observed in follow-up CSF samples. Conclusion: The present study suggests that in infectious CNS diseases an elevated IgG-Index might be an additional marker for the early identification of patients at risk for neurological morbidity. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
28. Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome.
- Author
-
Laureys, Steven, Celesia, Gastone G., Cohadon, Francois, Lavrijsen, Jan, León-Carrión, José, Sannita, Walter G., Sazbon, Leon, Schmutzhard, Erich, von Wild, Klaus R., Zeman, Adam, and Dolce, Giuliano
- Subjects
COMA ,LOSS of consciousness ,AKINETIC mutism ,BRAIN stem diseases ,MEDICINE - Abstract
Background: Some patients awaken from coma (that is, open the eyes) but remain unresponsive (that is, only showing reflex movements without response to command). This syndrome has been coined vegetative state. We here present a new name for this challenging neurological condition: unresponsive wakefulness syndrome (abbreviated UWS). Discussion: Many clinicians feel uncomfortable when referring to patients as vegetative. Indeed, to most of the lay public and media vegetative state has a pejorative connotation and seems inappropriately to refer to these patients as being vegetable-like. Some political and religious groups have hence felt the need to emphasize these vulnerable patients' rights as human beings. Moreover, since its first description over 35 years ago, an increasing number of functional neuroimaging and cognitive evoked potential studies have shown that physicians should be cautious to make strong claims about awareness in some patients without behavioral responses to command. Given these concerns regarding the negative associations intrinsic to the term vegetative state as well as the diagnostic errors and their potential effect on the treatment and care for these patients (who sometimes never recover behavioral signs of consciousness but often recover to what was recently coined a minimally conscious state) we here propose to replace the name. Conclusion: Since after 35 years the medical community has been unsuccessful in changing the pejorative image associated with the words vegetative state, we think it would be better to change the term itself. We here offer physicians the possibility to refer to this condition as unresponsive wakefulness syndrome or UWS. As this neutral descriptive term indicates, it refers to patients showing a number of clinical signs (hence syndrome) of unresponsiveness (that is, without response to commands) in the presence of wakefulness (that is, eye opening). [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
29. Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
- Author
-
Lackner, Peter, Part, Andrea, Burger, Christoph, Dietmann, Anelia, Broessner, Gregor, Helbok, Raimund, Reindl, Markus, Schmutzhard, Erich, and Beer, Ronny
- Subjects
CEREBRAL malaria ,MORTALITY ,DRUGS ,MULTIPLE sclerosis ,PLASMODIUM ,APOPTOSIS ,IMMUNE response - Abstract
Background: Cerebral malaria (CM) is associated with high mortality and morbidity caused by a high rate of transient or persistent neurological sequelae. Studies on immunomodulatory and neuroprotective drugs as ancillary treatment in murine CM indicate promising potential. The current study was conducted to evaluate the efficacy of glatiramer acetate (GA), an immunomodulatory drug approved for the treatment of relapsing remitting multiple sclerosis, in preventing the death of C57Bl/6J mice infected with Plasmodium berghei ANKA. Methods and Results: GA treatment led to a statistically significant lower risk for developing CM (57.7% versus 84.6%) in treated animals. The drug had no effect on the course of parasitaemia. The mechanism of action seems to be an immunomodulatory effect since lower IFN-gamma levels were observed in treated animals in the early course of the disease (day 4 post-infection) which also led to a lower number of brain sequestered leukocytes in treated animals. No direct neuro-protective effect such as an inhibition of apoptosis or reduction of micro-bleedings in the brain was found. Conclusion: These findings support the important role of the host immune response in the pathophysiology of murine CM and might lead to the development of new adjunctive treatment strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
30. Scanning electron microscopy of the neuropathology of murine cerebral malaria.
- Author
-
Lackner, Peter, Beer, Ronny, Helbok, Raimund, Broessner, Gregor, Engelhardt, Klaus, Brenneis, Christian, Schmutzhard, Erich, and Pfaller, Kristian
- Subjects
CEREBRAL malaria ,SCANNING electron microscopy ,NEUROLOGICAL disorders ,ANIMAL models in research ,HISTOPATHOLOGY ,PLASMODIUM - Abstract
Background: The mechanisms leading to death and functional impairments due to cerebral malaria (CM) are yet not fully understood. Most of the knowledge about the pathomechanisms of CM originates from studies in animal models. Though extensive histopathological studies of the murine brain during CM are existing, alterations have not been visualized by scanning electron microscopy (SEM) so far. The present study investigates the neuropathological features of murine CM by applying SEM. Methods: 57BL/6J mice were infected with Plasmodium berghei ANKA blood stages. When typical symptoms of CM developed perfused brains were processed for SEM or light microscopy, respectively. Results: Ultrastructural hallmarks were disruption of vessel walls, parenchymal haemorrhage, leukocyte sequestration to the endothelium, and diapedesis of macrophages and lymphocytes into the Virchow-Robin space. Villous appearance of observed lymphocytes were indicative of activated state. Cerebral oedema was evidenced by enlargement of perivascular spaces. Conclusion: The results of the present study corroborate the current understanding of CM pathophysiology, further support the prominent role of the local immune system in the neuropathology of CM and might expose new perspectives for further interventional studies. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
31. Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study.
- Author
-
Tegtmeier, Frank, Schinzel, Reinhard, Beer, Ronny, Bulters, Diederik, LeFrant, Jean-Yves, Sahuquillo, Joan, Unterberg, Andreas, Andrews, Peter, Belli, Antonio, Ibanez, Javier, Lagares, Alfonso, Mokry, Michael, Willschke, Harald, Flüh, Charlotte, Schmutzhard, Erich, and NOSTRA Investigators
- Subjects
BRAIN injuries ,PERSONAL names - Abstract
After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe.
- Author
-
Laranjo-González M, Devleesschauwer B, Trevisan C, Allepuz A, Sotiraki S, Abraham A, Afonso MB, Blocher J, Cardoso L, Correia da Costa JM, Dorny P, Gabriël S, Gomes J, Gómez-Morales MÁ, Jokelainen P, Kaminski M, Krt B, Magnussen P, Robertson LJ, Schmidt V, Schmutzhard E, Smit GSA, Šoba B, Stensvold CR, Starič J, Troell K, Rataj AV, Vieira-Pinto M, Vilhena M, Wardrop NA, Winkler AS, and Dermauw V
- Subjects
- Animal Husbandry, Animals, Cattle, Cattle Diseases parasitology, Cattle Diseases transmission, Cysticercosis parasitology, Cysticercosis transmission, Cysticercosis veterinary, Europe epidemiology, Humans, Neurocysticercosis epidemiology, Neurocysticercosis parasitology, Prevalence, Public Health, Swine, Swine Diseases parasitology, Swine Diseases transmission, Taenia saginata isolation & purification, Taenia solium isolation & purification, Taeniasis parasitology, Taeniasis transmission, Taeniasis veterinary, Cattle Diseases epidemiology, Cysticercosis epidemiology, Swine Diseases epidemiology, Taeniasis epidemiology
- Abstract
Background: Taenia solium and Taenia saginata are zoonotic parasites of public health importance. Data on their occurrence in humans and animals in western Europe are incomplete and fragmented. In this study, we aimed to update the current knowledge on the epidemiology of these parasites in this region., Methods: We conducted a systematic review of scientific and grey literature published from 1990 to 2015 on the epidemiology of T. saginata and T. solium in humans and animals. Additionally, data about disease occurrence were actively sought by contacting local experts in the different countries., Results: Taeniosis cases were found in twelve out of eighteen countries in western Europe. No cases were identified in Iceland, Ireland, Luxembourg, Norway, Sweden and Switzerland. For Denmark, Netherlands, Portugal, Slovenia, Spain and the UK, annual taeniosis cases were reported and the number of detected cases per year ranged between 1 and 114. Detected prevalences ranged from 0.05 to 0.27%, whereas estimated prevalences ranged from 0.02 to 0.67%. Most taeniosis cases were reported as Taenia spp. or T. saginata, although T. solium was reported in Denmark, France, Italy, Spain, Slovenia, Portugal and the UK. Human cysticercosis cases were reported in all western European countries except for Iceland, with the highest number originating from Portugal and Spain. Most human cysticercosis cases were suspected to have acquired the infection outside western Europe. Cases of T. solium in pigs were found in Austria and Portugal, but only the two cases from Portugal were confirmed with molecular methods. Germany, Spain and Slovenia reported porcine cysticercosis, but made no Taenia species distinction. Bovine cysticercosis was detected in all countries except for Iceland, with a prevalence based on meat inspection of 0.0002-7.82%., Conclusions: Detection and reporting of taeniosis in western Europe should be improved. The existence of T. solium tapeworm carriers, of suspected autochthonous cases of human cysticercosis and the lack of confirmation of porcine cysticercosis cases deserve further attention. Suspected cases of T. solium in pigs should be confirmed by molecular methods. Both taeniosis and human cysticercosis should be notifiable and surveillance in animals should be improved.
- Published
- 2017
- Full Text
- View/download PDF
33. Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions--a prospective multicenter cohort study.
- Author
-
Schmutzhard J, Lackner P, Helbok R, Hurth HV, Aregger FC, Muigg V, Kegele J, Bunk S, Oberhammer L, Fischer N, Pinggera L, Otieno A, Ogutu B, Agbenyega T, Ansong D, Adegnika AA, Issifou S, Zorowka P, Krishna S, Mordmüller B, Schmutzhard E, and Kremsner P
- Subjects
- Child, Child, Preschool, Cohort Studies, Female, Gabon, Ghana, Hearing Loss epidemiology, Humans, Kenya, Male, Prospective Studies, Hearing Loss etiology, Malaria, Cerebral complications, Malaria, Falciparum complications, Otoacoustic Emissions, Spontaneous
- Abstract
Background: Severe malaria may influence inner ear function, although this possibility has not been examined prospectively. In a retrospective analysis, hearing impairment was found in 9 of 23 patients with cerebral malaria. An objective method to quickly evaluate the function of the inner ear are the otoacoustic emissions. Negative transient otoacoustic emissions are associated with a threshold shift of 20 dB and above., Methods: This prospective multicenter study analyses otoacoustic emissions in patients with severe malaria up to the age of 10 years. In three study sites (Ghana, Gabon, Kenya) 144 patients with severe malaria and 108 control children were included. All malaria patients were treated with parental artesunate., Results: In the control group, 92.6 % (n = 108, 95 % confidence interval 86.19-6.2 %) passed otoacoustic emission screening. In malaria patients, 58.5 % (n = 94, malaria vs controls p < 0.001, 95 % confidence interval 48.4-67.9 %) passed otoacoustic emission screening at the baseline measurement. The value increased to 65.2 % (n = 66, p < 0.001, 95 % confidence interval 53.1-75.5 %) at follow up 14-28 days after diagnosis of malaria. The study population was divided into severe non-cerebral malaria and severe malaria with neurological symptoms (cerebral malaria). Whereas otoacoustic emissions in severe malaria improved to a passing percentage of 72.9 % (n = 48, 95 % confidence interval 59-83.4 %) at follow-up, the patients with cerebral malaria showed a drop in the passing percentage to 33 % (n = 18) 3-7 days after diagnosis. This shows a significant impairment in the cerebral malaria group (p = 0.012 at days 3-7, 95 % confidence interval 16.3-56.3 %; p = 0.031 at day 14-28, 95 % confidence interval 24.5-66.3 %)., Conclusion: The presented data show that 40 % of children have involvement of the inner ear early in severe malaria. In children, audiological screening after severe malaria infection is not currently recommended, but is worth investigating in larger studies.
- Published
- 2015
- Full Text
- View/download PDF
34. Apoptosis of the fibrocytes type 1 in the spiral ligament and blood labyrinth barrier disturbance cause hearing impairment in murine cerebral malaria.
- Author
-
Schmutzhard J, Kositz CH, Glueckert R, Schmutzhard E, Schrott-Fischer A, and Lackner P
- Subjects
- Animals, Caspase 3 analysis, Connexin 26, Connexins analysis, Disease Models, Animal, Immunohistochemistry, Mice, Mice, Inbred C57BL, Microscopy, Apoptosis, Hearing Loss etiology, Hearing Loss physiopathology, Labyrinth Diseases pathology, Malaria, Cerebral complications, Malaria, Cerebral pathology, Spiral Ligament of Cochlea pathology
- Abstract
Background: Experimental murine malaria has been shown to result in significant hearing impairment. Microscopic evaluation of the temporal bones of these animals has revealed regular morphology of the cochlea duct. Furthermore, the known vascular pathologic changes being associated with malaria could not be found. Immunohistochemistry for ICAM1 showed a strong marking in the stria vascularis, indicating a disturbance of the endocochlear potential. The aim of this study was to evaluate the role of apoptosis and the disturbance of the blood labyrinth barrier in the murine malaria associated hearing impairment., Methods: The temporal bones of seven mice with cerebral malaria-four with hearing impairment, three without hearing impairment-were evaluated with immunohistochemistry for cleaved caspase 3 to detect apoptosis and connexin 26, a gap junction protein being a cornerstone in the endocochlear potassium recirculation. Furthermore five animals with cerebral malaria were treated with Evans blue prior to sacrification to detect disturbances of the blood labyrinth barrier., Results: Cleaved caspase 3 could clearly be detected by immunohistochemistry in the fibrocytes of the spiral ligament, more intensively in animals with hearing impairment, less intensively in those without. Apoptosis signal was equally distributed in the spiral ligament as was the connexin 26 gap junction protein. The Evans blue testing revealed a strong signal in the malaria animals and no signal in the healthy control animals., Conclusion: Malfunction of the fibrocytes type 1 in the spiral ligament and disruption of the blood labyrinth barrier, resulting in a breakdown of the endocochlear potential, are major causes for hearing impairment in murine cerebral malaria.
- Published
- 2012
- Full Text
- View/download PDF
35. Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study.
- Author
-
Lackner P, Kuenz B, Reindl M, Morandell M, Berger T, Schmutzhard E, and Eggers C
- Subjects
- AIDS Dementia Complex drug therapy, AIDS Dementia Complex pathology, AIDS Dementia Complex physiopathology, Adult, Anti-HIV Agents therapeutic use, Autoantibodies immunology, Brain immunology, Brain pathology, Brain physiopathology, Cohort Studies, Cross-Sectional Studies, Female, HIV-1 immunology, Humans, Inflammation immunology, Middle Aged, Myelin Proteins, Myelin-Oligodendrocyte Glycoprotein, RNA, Viral blood, Sensitivity and Specificity, Viral Load, AIDS Dementia Complex metabolism, Autoantibodies blood, Autoantibodies cerebrospinal fluid, Myelin-Associated Glycoprotein immunology
- Abstract
Background: Neuroinflammation and demyelination have been suggested as mechanisms causing HIV-1 associated neurocognitive disorder (HAND). This cross-sectional cohort study explores the potential role of antibodies to myelin oligodendrocyte glycoprotein (MOG), a putative autoantigen in multiple sclerosis, in the pathogenesis of HAND., Methods: IgG antibodies against MOG were measured by ELISA in sera and cerebrospinal fluid (CSF) of 65 HIV-positive patients with HAND (n = 14), cerebral opportunistic infections (HIVOI, n = 25), primary HIV infection (HIVM, n = 5) and asymptomatic patients (HIVasy, n = 21). As control group HIV-negative patients with bacterial or viral CNS infections (OIND, n = 18) and other neurological diseases (OND, n = 22) were included. In a subset of HAND patients MOG antibodies were determined before and during antiviral therapy., Results: In serum, significantly higher MOG antibody titers were observed in HAND compared to OND patients. In CSF, significantly higher antibody titers were observed in HAND and HIVOI patients compared to HIVasy and OND patients and in OIND compared to OND patients. CSF anti-MOG antibodies showed a high sensitivity and specificity (85.7% and 76.2%) for discriminating patients with active HAND from asymptomatic HIV patients. MOG immunopositive HAND patients performed significantly worse on the HIV dementia scale and showed higher viral load in CSF. In longitudinally studied HAND patients, sustained antibody response was noted despite successful clearance of viral RNA., Conclusions: Persistence of MOG antibodies despite viral clearance in a high percentage of HAND patients suggests ongoing neuroinflammation, possibly preventing recovery from HAND.
- Published
- 2010
- Full Text
- View/download PDF
36. IgG-index predicts neurological morbidity in patients with infectious central nervous system diseases.
- Author
-
Lackner P, Guengoer E, Beer R, Broessner G, Helbok R, Deisenhammer F, Schmutzhard E, and Pfausler B
- Subjects
- Adult, Aged, Cerebrospinal Fluid chemistry, Cerebrospinal Fluid cytology, Cross-Sectional Studies, Female, Humans, Male, Meningeal Neoplasms immunology, Meningitis, Bacterial immunology, Meningitis, Bacterial microbiology, Meningoencephalitis immunology, Meningoencephalitis virology, Middle Aged, Prognosis, Retrospective Studies, Treatment Outcome, Immunoglobulin G cerebrospinal fluid, Meningeal Neoplasms diagnosis, Meningeal Neoplasms secondary, Meningitis, Bacterial diagnosis, Meningoencephalitis diagnosis
- Abstract
Background: Prognosis assessment of patients with infectious and neoplastic disorders of the central nervous system (CNS) may still pose a challenge. In this retrospective cross-sectional study the prognostic value of basic cerebrospinal fluid (CSF) parameters in patients with bacterial meningitis, viral meningoencephalitis and leptomeningeal metastases were evaluated., Methods: White blood cell count, CSF/serum glucose ratio, protein, CSF/serum albumin quotient and Immunoglobulin indices for IgG, IgA and IgM were analyzed in 90 patients with bacterial meningitis, 117 patients with viral meningoencephalitis and 36 patients with leptomeningeal metastases in a total of 480 CSF samples., Results: In the initial spinal tap, the IgG-index was the only independent predictor for unfavorable outcome (GOS < 5) in patients with infectious CNS diseases but not in patients with leptomeningeal metastases. The sensitivity and specificity of an IgG-index of 0.75 and higher for predicting unfavorable outcome was 40.9% and 80.8% in bacterial meningitis and 40% and 94.8% in viral meningoencephalitis, respectively. No significant associations between CSF parameters and outcome could be observed in follow-up CSF samples., Conclusion: The present study suggests that in infectious CNS diseases an elevated IgG-Index might be an additional marker for the early identification of patients at risk for neurological morbidity.
- Published
- 2010
- Full Text
- View/download PDF
37. Cardiovascular autonomic function tests in an African population.
- Author
-
Torsvik M, Häggblom A, Eide GE, Schmutzhard E, Vetvik K, and Winkler AS
- Abstract
Background: Diabetes mellitus is becoming increasingly common in sub-Saharan Africa. Autonomic dysfunction contributes to morbidity and mortality in diabetic patients. Data on autonomic dysfunction in the African population is scarce, and no reference values for standardized autonomic function tests are available. The aim of this study was to establish cut off values for five easy-to-use cardiovascular autonomic function tests that may be suitable for resource-poor settings., Methods: We recruited 276 healthy African individuals, 156 men and 120 women, aged > 20 years. Participants were tested for (1) resting heart rate (HR), (2) HR variation in response to deep breathing, (3) HR response to standing, and (4) postural changes in systolic and diastolic blood pressure (SBP and DBP). Respective cut-off values were calculated according to the 95th or 5th percentile., Results: Taking an association of the autonomic test results with gender and age into consideration, we defined the following cut-off values: resting HR (bpm) >or= 89 for men and >or= 97 for women; HR (bpm) in response to deep breathing
or= 17 mmHg for all age groups; and postural decreases in DBP (mmHg) >or= 2 for men and >or= 5 for women., Conclusion: The test battery revealed cut-off values different from those measured in Caucasians. Further studies are recommended a) to assess whether these cut off values are generally applicable, and b) to establish population specific reference values for Africans. - Published
- 2008
- Full Text
- View/download PDF
38. Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria.
- Author
-
Dietmann A, Lackner P, Helbok R, Spora K, Issifou S, Lell B, Reindl M, Kremsner PG, and Schmutzhard E
- Subjects
- Analysis of Variance, Animals, Antimalarials therapeutic use, Case-Control Studies, Child, Child, Preschool, Drug Combinations, Endothelium, Vascular immunology, Enzyme-Linked Immunosorbent Assay, Female, Gabon epidemiology, Humans, Infant, Malaria, Falciparum blood, Malaria, Falciparum drug therapy, Malaria, Falciparum parasitology, Male, Pyrimethamine therapeutic use, Quinine therapeutic use, Statistics, Nonparametric, Sulfadoxine therapeutic use, Endothelin-1 blood, Malaria, Falciparum immunology, Natriuretic Peptide, C-Type blood, Plasmodium falciparum immunology
- Abstract
Background: Molecular mechanisms involved in the pathogenesis of severe Plasmodium falciparum malaria (SM), are not yet fully understood. Both endothelin-1 (ET-1) and C-type natriuretic peptide (CNP) are produced by vascular endothelium and act locally as paracrine regulators of vascular tone, ET-1 being a potent vasoconstrictor and CNP having strong vasorelaxant properties., Methods: Plasma levels of ET-1 and N-terminal fragments of CNP (NT-proCNP) were studied on admission and after 24 hours of treatment, using enzyme-linked-immunosorbent-assay (ELISA) technique, in Gabonese children with severe falciparum malaria (SM, n = 50), with uncomplicated malaria (UM, n = 39) and healthy controls (HC, n = 25)., Results: Compared to HC, malaria patients had significantly higher plasma levels of ET-1 and significantly lower levels of NT-proCNP (p < 0.001 and p < 0.024 respectively). Plasma levels of NT-proCNP were additionally decreased in SM patients compared to HC (p = 0.034), whereas UM was not significantly different to HC. In the SM group we found a trend towards lower ET-1 levels compared to UM (p = 0.085)., Conclusion: In the present study, an imbalance between the vasoconstricitve and vasorelaxant endothelium-derived substances ET-1 and CNP in the plasma of children with falciparum malaria is demonstrated, presumably in favor of vasoconstrictive and pro-inflammatory effects. These results may indicate involvement of ET-1 and CNP in malaria pathogenesis. Furthermore, results of lower ET-1 and CNP levels in SM may reflect endothelial cell damage.
- Published
- 2008
- Full Text
- View/download PDF
39. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].
- Author
-
Martinez-Torres F, Menon S, Pritsch M, Victor N, Jenetzky E, Jensen K, Schielke E, Schmutzhard E, de Gans J, Chung CH, Luntz S, Hacke W, and Meyding-Lamadé U
- Subjects
- Adult, Aged, Aged, 80 and over, Chemotherapy, Adjuvant, Double-Blind Method, Drug Therapy, Combination, Glucocorticoids therapeutic use, Humans, Middle Aged, Patient Selection, Research Design, Treatment Outcome, Young Adult, Acyclovir therapeutic use, Anti-Inflammatory Agents therapeutic use, Antiviral Agents therapeutic use, Dexamethasone therapeutic use, Encephalitis, Herpes Simplex drug therapy
- Abstract
Background: The treatment of Herpes-simplex-virus-encephalitis (HSVE) remains a major unsolved problem in Neurology. Current gold standard for therapy is acyclovir, a drug that inhibits viral replication. Despite antiviral treatment, mortality remains up to 15%, less than 20% of patients are able to go back to work, and the majority of patients suffer from severe disability. This is a discouraging, unsatisfactory situation for treating physicians, the disabled patients and their families, and constitutes an enormous burden to the public health services. The information obtained from experimental animal research and from recent retrospective clinical observations, indicates that a substantial benefit in outcome can be expected in patients with HSVE who are treated with adjuvant dexamethasone. But currently there is no available evidence to support the routine use of adjuvant corticosteroid treatment in HSVE. A randomized multicenter trial is the only useful instrument to address this question., Design: GACHE is a multicenter, randomized, double-blind, placebo-controlled, parallel group clinical trial of treatment with acyclovir and adjuvant dexamethasone, as compared with acyclovir and placebo in adults with HSVE. The statistical design will be that of a 3-stage-group sequential trial with potential sample size adaptation in the last stage., Conclusion: 372 patients with proven HSVE (positive HSV-DNA-PCR), aged 18 up to 85 years; with focal neurological signs no longer than 5 days prior to admission, and who give informed consent will be recruited from Departments of Neurology of academic medical centers in Germany, Austria and The Netherlands. Sample size will potentially be extended after the second interim analysis up to a maximum of 450 patients., Trial Registration: Current Controlled TrialsISRCTN45122933.
- Published
- 2008
- Full Text
- View/download PDF
40. Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.
- Author
-
Lackner P, Hametner C, Beer R, Burger C, Broessner G, Helbok R, Speth C, and Schmutzhard E
- Subjects
- Animals, Blotting, Western, Complement C1q immunology, Complement C3 immunology, Complement C5 immunology, Mice, Mice, Inbred C57BL, Plasmodium berghei immunology, Severity of Illness Index, Statistics as Topic, Brain immunology, Brain pathology, Brain Chemistry, Complement C1q analysis, Complement C3 analysis, Complement C5 analysis, Malaria, Cerebral immunology, Malaria, Cerebral pathology
- Abstract
Background: The patho-mechanisms leading to brain damage due to cerebral malaria (CM) are yet not fully understood. Immune-mediated and ischaemic mechanisms have been implicated. The role of complement factors C1q, C3 and C5 for the pathogenesis of CM were investigated in this study., Methods: C57BL/6J mice were infected with Plasmodium berghei ANKA blood stages. The clinical severity of the disease was assessed by a battery of 40 standardized tests for evaluating neurological functions in mice. Brain homogenates and sera of mice with CM, infected animals without CM and non-infected control animals were analyzed for C1q, C3 and C5 up-regulation by Western blotting., Results: Densitometric analysis of Western blots of brain homogenates yielded statistically significant differences in the levels of C1q and C5 in the analyzed groups. Correlation analysis showed a statistically significant association of C1q and C5 levels with the clinical severity of the disease. More severely affected animals showed higher levels of C1q and C5. No differences in complement levels were observed between frontal and caudal parts of the brain. Densitometric analysis of Western blot of sera yielded statistically lower levels of C1q in infected animals without CM compared to animals of the control group., Conclusion: The current study provides direct evidence for up-regulation of complement factors C1q and C5 in the brains of animals with CM. Local complement up-regulation is a possible mechanism for brain damage in experimental cerebral malaria.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.